Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Pozycja w akcjach #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Cena akcji
$0.117
Ostatnia synchronizacja: 2025-04-04
Kapitalizacja rynkowa
$2.45M
Zmiana (1 dzień)
-13.59%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Carmell Therapeutics Corporation (CTCX)

Kategoria

Wskaźnik P/B dla Carmell Therapeutics Corporation (CTCX)
Wskaźnik P/B na dzień August 2026 TTM: -0.06
Według najnowszych raportów finansowych i ceny akcji Carmell Therapeutics Corporation, obecny wskaźnik P/B (TTM) wynosi -0.06. Na koniec 2023 wynosił 95.93.
Historia wskaźnika P/B dla Carmell Therapeutics Corporation od 2021 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
2026 (TTM) -0.06 -99.85%
2024 -37.13 -138.70%
2023 95.93 -161.62%
2022 -155.68 -19.29%
2021 -192.90 0.00%
Wskaźnik P/B dla podobnych firm lub konkurentów
Firma Wskaźnik P/B Różnica wskaźnika P/B Kraj
6.3419 -11,404.63%
US
6.2413 -11,225.31%
NL
- -
CH
- -
KR
3.4612 -6,269.70%
BE